Background: The Receptor of advanced glycation endproducts (RAGE), as a member of the immunglobulin superfamily, is a new inflammation perpetuating multiligand receptor. Recent data suggest (i) that RAGE perpetuate and amplify inflammation and (ii) that targeting this receptor might attenuate hyperinflammation1. RAGE has soluble isoforms refered to as total sRAGE, that comprise the extracellular ligand-binding domain but are lacking the cytosolic and transmembrane domains. Actually, there is a lack of knowledge regarding the role of sRAGE in human sepsis. In view of these data, the aim of this work was (i) to investigate whether total pool of sRAGE is increased in plasma of septic patients and (ii) to assese the ability of sRAGE to predict mortality in patients with severe sepsis or septic shock. Design: Observational clinical study. Setting: Surgical intensive care unit of the University Hospital of Heidelberg, Germany. Patients: Patients admitted to the intensive care unit over a 6-month period with clinical evidence of severe sepsis or septic shock and eight healthy controls. Interventions: None. Measurements and Main Results: Twenty-nine intensive care patients were enrolled in the study within the first 24 h after onset of severe sepsis or septic shock. Eight healthy controls served as controls. Plasma sRAGE concentrations were elevated in septic patients compared with healthy volunteers (1.764 ± 138 vs. 1.026 ± 177, p < 0.05). Additionally, nonsurvivors after 28 days have had higher plasma sRAGE concentrations than survivors (2.302 ± 189 vs. 1.326 ± 112, p < 0.001). ROC curve analysis of plasma sRAGE concentrations of septic patients showed a specificity of 75 % and a sensitivity of 84.6 % with 1596 pg/ml as cutoff. Conclusion: This is the first study showing elevated plasma sRAGE concentrations in septic patients. Noteworthy, nonsurvivors had higher plasma sRAGE concentrations tha n survivors suggesting that sRAGE is related to severity and outcome of septic patients and may serve as a new sepsis marker. Venous catheter bacteriological monitoring. Necessity or habit?
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Introduction: Catheter in the central venous system may be a source of generalized infection, due to its invasive nature, maintaining time and the patient life-threatening condition, causing prolongation of ICU and hospital stay, increasing mortality and the entire costs of treatment. In septic patients, especially if the bacteriemia is suspected, intravenous catheter (IVC) is removed and tip is microbiologically examined. Objective: We focused on the bacteriological analysis of IVC tips and the assesment of the frequency of the catheter-related blood infections (CR-BSI). Our goal was also to estimate the economical and clinical purposefulness of microbiological IVC tips analysis. Methods: The study was conducted at an adult 7-bed surgical/medical ICU between 1.X.2004 -31.VII 2006. We retrospectively studied IVC tips and blood culture obtained from 120 septic patients (32,9% of all patients treated during that period). Maximal barrier precautions (MBP) -hand washing, sterile site preparation, use of hut, mask, gloves, gown and sterile dressing application were always implemented when introducing IVC. CR-BSI was defined according to the CDC guidelines -positive IVC tip cultures with an associated positive blood culture (collected from separate approach) and the exclusion of different source of bacteriemia. Catheter removing was performed in case of prolonged time of catheter insertion or when the clinical state of patient indicated that catheter was the possible source of infection or when the inflammation of the puncture site was observed. Cost information was obtained from microbiological laboratory. Results: We examined 238 IVC tips. In 123 IVC tips (51,6%) we didn't culture any pathogens. The rest of studied 115 (48,4%) IVC tips was positive. Of these 115 tips cultured, we isolated in 89 cases 1 type of pathogen, in 21 cases 2 and in 5 cases we found 3. Of 723 blood samples cultured, 181 (24,1%) indicated bacteriemia and 168 was collected in the same time as IVC was removed. It was found that in 25 cases (3% of blood samples) taken from 20 patients, the same pathogens were isolated from IVC tips. We cultured: Staph. epidermidis (8 cases), P. mirabilis (5), E. cloacae (3), Staph. aureus (2), Ps. aeruginosa (2), C. albicans (2), C. parapsilosis (2), Staph. haemolyticus (1), Ac. baumanii (1) and Ent. faecalis (1) (in 2 cases 2 pathogenes were isolated). In 12 cases the same pathogens in blood and IVC tips were also cultured in other places -BAL (6), abdomen (3), bed-sore (2), urinary tract (1). In 13 cases (5,5% of tips) IVC's were the source of CR-BSI. Positive pred ictive value (PPV) and negative predictive value (NPV) amount to 11% and 91%, respectively. Sensitivity and specificity of the method is 54% and 52%, respectively. Time of maintenance of IVC amounted to 5-21 days. The laboratory cost of processing a negative tip culture was 11 € , while a positive tip culture 20 -45 €, depending on the number of pathogens. The total cost of IVC tips microbiological examination amounted to about 4000 €. Conclusions: 1. Bacterial colonisation of IVC is rarely responsible for CR-BSI. 2. Relatively low PPV (11%) makes a IVC tips culture as a method of diagnosing CR-BSI useless. 3. Economically, routine bacterial monitoring of IVC tips seems to be not justifiable. 4. Taking all these into account we decided to discontinue the routine culture of IVC tip for the diagnosis of CR-BSI.
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Implementing a sepsis therapy concept conforming to regulatory requirements in a regular hospital setting and establishment of a local sepsis therapy network
Bier M Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Kreiskrankenhaus Ottweiler
Introduction: In recent years, numerous innovations in diagnosis and therapy of sepsis have been integrated into normal hospital routine operations (1,2). Some remarkable research (3) has clearly demonstrated the possibility to significantly reduce lethality rates related to septic shocks through proper implementation of those evidence based innovations in sepsis therapy and diagnosis. However, this research was conducted in university hospital settings with above average resources compared to regular hospitals.
Methods:
The remaining challenge has been to implemented appropriate methods to enable proper treatment of patients in regular hospital settings conforming to regulatory requirements . That challenge could be successfully met by implementing the following methods: 1)Implementation of SOP's, Distribution and Publication on the Intranet, Training of Medical Personnel, Establishment of a qualified 'On-Call' Function 2)Cooperation with neighbouring hospitals spe-cialized in sepsis therapy and diagnosis and specialized treatment/diagnosis centres to achieve the following goals: -Exchange of Information -Access to specialized and expensive pharmaceuticals (Xigris © , Voriconazole, etc.) and diagnostics (e.g. Septifast © ) -Possibility of patient transfers if own hospital resources are not sufficient (e.g. Liver replacement therapy, specialized surgery) 3)Organization of training courses and implementation of quality review circles bringing together people from all hospital settings with different background and resources ( e.g. local hospitals and specialized care centres) Results: Through implementation of the methods described above, modern sepsis diagnosis and therapy concepts were succesfully implemented in regular hospital settings conforming to regulatory requirements. Those methods mentioned above were further supplemented by the following measures: Improvement of logistics of specialized pharmaceuticals and diagnostics to facilitate access Implementation of Continous renal replacement therapy, Weaning protocols and , education of the medical staff (nursery and physician), qualified On Call Function. The close cooperation with neighbouring intensive care centres resulted in a better utilization of available resources across all levels of patient care. Avoidance of unnecessary inter-hospital patient transfers, early transfer to appropriate hospital based on indication.
Conclusion:
A modern and innovative therapy and diagnosis of sepsis conforming to guidelines is also possible in a regular hospital setting References: 1)Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock. Crit Care Med 2004;32(3):858-873 2)Diagnosis and therapy of sepsis -Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Association for Intensive and Emergency Medicine. A&I 2006, 11: S157-S180 3)Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Correlation between procalcitonin, EuroSCORE and SOFA score during the intensive care unit course in patients subjected to cardiac surgery
*Maravic-Stojkovic V (1), Spasic T (1), Jovic M (1), Borzanovic M (1), Djukanovic B (1), Brunner D (2)
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Introduction:
We recently reported the clinical course of patients with good left ventricle ejection fraction (LVEF) by assessing Sequential Organ Failure (SOFA) score and procalcitonin (PCT) serum concentrations as prognostic markers early after cardiac surgery. Methods: In this study we observed patients with systolic heart failure (HF), prospectively collecting clinical and laboratory data: B-type natriuretic peptide (BNP), PCT, and SOFA score in patients admitted to intensive care unit. Aim To examine whether PCT levels differ in patients with and without HF subjected to the open heart surgery. Methods In RCT study, 307 patients (age 59.84±9.55 years, 65.5% male) subjected to CABG, valve procedures or combined CABG and valve operations were divided in three groups: A (n=103) with echocardiographically estimated LVEF>30% on standard care as control; B (n=102) for procalcitonin guided antibiotic treatment; C (n=102) with LVEF<30% for BNP analysis. The predicted surgical risk was calculated according to EuroSCORE. The significance of the immune activation was assessed by PCT and C-reactive protein (CRP) serum concentrations. PCT and CRP were measured preoperatively, 6h, 24h and 48h postoperatively. BNP was measured preoperatively in patients with HF. SOFA score was assessed daily as SOFA1, SOFA2, SOFA3, SOFAAUC. Operation data, laboratory data, and clinical outcomes were observed. Objective is to present a management of the sepsis due to bronchial stump insufficiency (BSI) empyema in a video demonstration. The film shows all the technical details of the management in a step by step manner. Methods: A 64-years old female patient with a history of 3 years chronic postlobectomy empyema due to BSI and failed repeated chest tube drainages was referred to our Institution. Initially, due to her poor condition and sepsis, the empyema cavity (after the right lower lobectomy) was drained under the CT control; a wide-spectrum combination of antibiotics was applied too. After the significant detoxication but still poor performance status, the BSI was tried to close endoscopically by endovascular coils and tissucol. The stump closure was obtained for several days, but was reopened under the spontaneous breathing and coughing acts of the patient. The same procedure was than repeated with a fibrin-glue application, but BSI appeared after 7 days again. 3 months after these unsuccessful endobronchial interventions, the limited thoracoplasty together with myoplasty (m.latissimus dorsi, m. serratus ant.) and debridment, re-closure of the bronchial stump was than performed. Results: Only after this active surgical access it was possible to discharge the patient with healed bronchial stump home. She left the hospital at the 35th postoperative day and today she is 20 Mo after the procedure without any signs of septic complication or recurrence of BSI.
Conclusion:
The post-interventional empyema with the sepsis after the BSI is still the feared complication with high morbidity and mortality rate. Endobronchial procedures for BSI are reported with controversial results in the literature. Due to the poor performance status, sepsis of the patient, the definitive endoscopic closure of the bronchial stump can only be hardly obtained. The definitive solution -surgical BSI closure combined by the myoplasty -and limited thoracoplasty (after the detoxication and stabilization of the patient) -is the recommended treatment for sepsis due to BSI empyema.
Introduction: Antibiotics are too often used without consideration of the creatinine clearance. Especially nephrotoxic antibiotics can lead to a further decline of renal function and sometimes even to the need of renal replacement therapy. Methods: For an easy calculation of the creatinine clearance and the adequate dosage of antibiotics and other drugs, we created the computer application www.intensivdocs.de, which is available everywhere through the internet. For most of the calculations and recommendations it is just necessary to enter the patients sex, age, height, weight and creatinine, using e.g. the Cockroft-Gault equation for creatinine clearance.
Results: Within seconds an patient individualized dosing schedule recommendation is given. The application also warns the user of potential hazards, for instance restrictions of use with declining renal function or important interactions with comedication, e.g. QT-time-prolongation. The included module for antibiotic therapy gives the senior intensivist the possibility to tailor the antibiotic therapy to his ICU, taking prevalence of multi resistant bacteria and local resistance statistics into account. Thereby he can share his knowledge with the junior ICU staff and keep a high standard 24 hours/7 days a week. Discussion: Especially for junior staff this application provides the necessary information fast and makes this information, through direct adjustment to the patient's needs, better applicable in an ICU environment than conventional means. The benefit for the patient is a safer, faster and more effective treatment.
This application is helpful in maximizing the benefit and reducing the risk of an antibiotic treatment for critically ill patients.
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Evaluation of clinical condition of the patients with severe sepsis treated with activated protein C:
an observational study had significantly lower mean SOFA score at baseline, comparing to non-survivors (8±2,8 vs.12±1,6). There was no significant difference in APACHE II score between groups at the entry to the study (20,7±6,0 in S group vs. 23,2±5,2 in NS group); APACHE II score decreased to 9,8±4,5 in S group and remained high 24,6±8,5 in NS group at the and of APC administration. CRP level was elevated at baseline in both groups (212,7±88,1 in S and 226,1±124,7 in NS). Marked decrease in CRP level was observed only in S group after 96h (74,8±56,2). Mean CRP value was also lower in NS group but the result was not statistically significant. At the entry to the study, elevated FDP level in all patients decreased in S group and increased in NS group (from 5852±2346 to 2865±1299 in S group vs. 6353±1099 to 8623±6706 in NS group at baseline and after 96h, respect ively). Conclusions: Both groups were characterized by similar clinical condition at baseline (APACHE II score), but in S group multiorgan failure was less severe (consistent with SOFA score). Delayed admission to ICU because of the late recognition of severe sepsis/septic shock was associated with a low efficiency of APC treatment and high mortality. Early recognition of severe sepsis and treatment with APC provides more benefit for the patients and is associated with a lower mortality. 
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Methods:
Patients with (n=32) and without (n=15) sepsis and healthy volunteers (n=15) were included in this study. Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll density gradient centrifugation and cEPC's were characterized by three-colour-fluorescence flowcytometry using antibodies against CD133, CD34 and vascular endothelial growth factor-Receptor (VEGF-R)-2. Serum-concentrations of vascular endothelial growth factor (VEGF), granulocyte macrophage-colony stimulating factor (GM-CSF) and erythropoietin (EPO) were determined by ELISA. Severity of sepsis was assessed according to APACHE II scoring.
Results:
In septic patients the number of cEPC's was significantly higher than in non-septic ICU-patients (p<0.05) and healthy controls (p<0.02). Non-survivors (n=8), defined as death within 28 days after onset of sepsis, had significant lower numbers of cEPC's than survivors (n=24) (p<0.0001). The number of cEPC's was correlated with survival in septic patients. Serum-VEGF-concentrations were significantly higher in septic patients compared to non-septic ICU-patients and healthy controls (p<0.01), and correlated with the cEPC's numbers (p<0.0001). Similar findings were observed for GM-CSF and EPO.
Conclusions:
Our data suggest that cEPC enumeration in peripheral blood of septic patients might be a valuable marker to assess the clinical outcome in these patients.
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Infection Introduction: Surviving Sepsis Campaign (SSC) proposed 6-hour resuscitation and 24-hour management bundles as a measure to reduce mortality in severe sepsis. This approach was recently adopted for use in Intensive Care Units (ICUs) in Poland and the first results of bundles' application are presented. Methods: At the beginning of January 2007 the sepsis bundle protocol was introduced as an additional option to the website-based severe sepsis registry program functioning in Poland since 2003. Results: Till June 2007 the first 120 cases of bundles' implementation were registered. The rate of compliance with the 6-hour resuscitation bundle was 11% and with the 24-hour management bundle was 36%. Despite the small number of patients and low compliance rate there was observed a distinct difference in mortality between compliant and non-compliant groups. The mortality rate in patients compliant with the resuscitation bundle was 38% and non-compliant 50%. Respectively, mortality in patients compliant and non-compliant with the management bundle was 37% and 55%.
Conclusion:
The preliminary results of sepsis bundles' implementation showed marked difference in mortality between compliant and noncompliant groups, that was beyond expectation for such a small population of patients. The bundle approach is now recommended for routine use in patients treated for severe sepsis in ICUs. In the nearest future it should provide more comprehensive and detailed analysis of data Results: From a total of 80 patients retrieved from the hospital information system, 40 were fulfilling the ACCP/SCCM-sepsis-criteria whereof 20 until now were susceptible for further analysis. In 6 of them a urogenital or a bronchopulmonary focus of sepsis could be detected, in 8 patients an abdominal or no specified focus could be detected. Gram-stain positive or negative bacterial specimens were found in 11 and 8 patients respectively. While no correlation could be detected between initial PCT-levels and maximum SOFA-score depending on gram-stain-character (R² < 0.2), a good correlation could be found in this relationship depending on sepsis-focus. Patients with a bronchopulmonary focus had much higher severity of illness with lower initial PCT-levels (y = 0.1319x + 9.5718, R² = 0.9557) than patients with urogenital focus (y = 0.026x + 4.2097, R² = 0.7755). For patients with suspected abdominal focus of sepsis, no correlation could be detected. Initial SAPS II-score and maximum SOFA-score also had a sufficient correlation but could not differentiate between pulmonary and urogenital focus. No correlation could be found between initial PCT and SAPS II and between initial and maximum CrP and maximum SOFA. Conclusion: Initial PCT-levels may probably allow to early predict the severity of illness depending on the suspected focus of infection. Further prospective evaluations are necessary to confirm this hypothesis.
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The activity of C-Protein in infants undergoing correction of congenital heart disease with the use of cardiopulmonary bypass -pilot study Introduction: Sepsis is a major complication in critically ill patients with a mortality rate as high as 50%. Crucial for successful treatment is the rapid identification of the causative agent in order to facilitate specific antimicrobial therapy. Objective: We evaluated a new PCR system designed to detect clinically relevant pathogens causing septicaemia in intensive care patients. Results were compared with conventional blood cultures (BC) and correlated with procalcitonin (PCT) as a clinical marker of sepsis. Methods: Patients enrolled in this study had evidence for a new focus of infection and a clinical suspicion for sepsis. Inclusion criteria were fever (> 38°C) or hypothermia (< 36°C) and additionally leucocytosis (> 12.000/µl), leucopenia (< 4.000/µl), leucocyte left shift (> 10%), tachycardia (> 90/min), tachypnoe (> 20/min) or hyperventilation (pCO2 < 33 mmHg). Blood (2x 10 ml) for BC was incubated under aerobic and anaerobic conditions using an automated CO2 detection system (BacTec, BD). For PCR an EDTA-blood sample (2x 3.5 ml) was drawn simultaneously and analysed using the SeptiFast-test on the LightCycler® system for real-time PCR (Roche Diagnostics.). Results: 56 pairs of samples from 44 individuals were analysed. PCR results were usually available on the same day (min. 6.5 h) while definitive BC results were reported at least two days later. BC and PCR were both negative in 30 (group A) and both positive in 13 cases (group B). Pathogens detected by both methods were K. pneumoniae, E. coli, S. aureus, E. faecium and C. albicans. In addition, K. pneumoniae, E. coli and E. cloacae were determined by PCR but not by BC. In 8 patients PCR was negative but BC was positive (group C) with 4 samples contaminated with dermal Streptococci deliberately not reported by the SeptiFast interpretive software. In another 3 cases two BC were drawn simultaneously with only one turning positive, in the remaining one patient E. faecium was detected by BC but not by PCR. Background: Arginine vasopressin (AVP) as the strongest endogenous vasopressor in terms of maximal contractile effect induced and its duration has found growing interest in the therapy of vasoplegic states, e.g. patients with septic shock. In parallel, in these patients a decrease of a metalloprotease (ADAMTS13) with inactivating activity against the ultra-large, highly thrombogenic form of Von Willebrand Factor (ULVWF) has been described. It is also known, that (i) subsequent formation of VWF-rich microthrombi impairs the microcirculatory state and (ii) administration of a stabilized analogue of AVP results in a decrease of ADAMTS13 by unknown mechanisms and the appearance of ULVWF in plasma of healthy individuals. Objective: to test the effect of AVP given in septic shock on mucosal microcirculation, hemodynamic parameters, urine output, haemostaseological parameters including ADAMTS13 and platelet count. Methods: 20 patients with septic shock were studied in a consecutive design (12 male, 8 female; aging 63; 35-78 years). AVP was administered in a dosage of 2 IU/kg/h over 2 hours. During the study period, norepinephrine infusion rate was reduced to keep mean arterial blood pressure constant. Hemodynamic and haemostaseological parameters, platelet count and urine output were analyzed. Oral mucosal tissue oxygen saturation (SO2), microcirculatory blood flow and flow velocity were measured with a laser Doppler flowmetry and remission spectroscopy system (O2C, LEA Medtechnik, Giessen). ADAMTS13 activity was determined using the Kokame method.
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Results: AVP administration did not change cardiac output, but resulted in significant decrease of oral mucosal oxygen saturation, blood flow and a significant decrease of flow velocity. Also we analyzed a significant decline of ADAMTS13 activity (0.92; 0.69-1.15 U/mL vs. 0.51; 0.39-059 U/mL) and of platelet count after 4 hours (75; 64-100 vs. 71; 55-87 Gpt/l). During AVP administration, norepinephrine dosage and heart rate dropped down significantly. Furthermore, urine output increased (125; 20-480 vs. 210; 30-690 ml/h). Conclusions: AVP administration causes a deterioration of oral mucosal blood flow independent of macrocirculatory conditions. This was accompanied by a further decrease of ADAMTS13 activity from declined baseline levels in patients with septic shock, which may result in secondary AVP induced platelet aggregation, collateral formation of VWF-rich microthrombi and subsequent occlusion of microvessels, which may be reflected by platelet consumption and impaired microcirculation after AVP infusion. Therefore, besides its beneficial vasoconstrictive effects, AVP administration may be reconsidered due to potential aggravation of organ dysfunction subsequent to triggering thrombotic-microangiopathic complications. Anti-platelet drugs reduce mortality in surgical and non-surgical ICU patients
(1) Department of Anaesthesiology and Intensive Care Therapy, University Jena, Germany, (2) Department for Anaesthesiology and Intensive Care, Clinical Centre Meiningen, Germany
Introduction: Platelet activation in sepsis may contribute to fatal outcome via thrombotic microangiopathy and modifying inflammatory reactions. Anti-platelet drugs such as acetylsalicylic acid or clopidogrel are used for secondary prevention of cardiovascular events and their effect lasts for upto 7 days after withdrawal. Objectives: We studied whether pre-hospital use of anti-platelet may reduce mortality in critically ill patients of either non-surgery or surgery/traumatic cause. Methods: 361 non-surgery and 254 surgery patients who were admitted to the intensive care unit (ICU) within 24 h of hospital treatment were included in a retrospective study. Elective surgery or use of statins were exclusion criteria. Results: 155 of the 615 patients were on anti-platelet drugs prior to hospitalisation. 84% were on acetylsalicylic acid, 6 % on clopidogrel and 10 % on a combination of ASS and clopidogrel. 45 % of patients developed sepsis, and the overall ICU mortality was 38 %. Pre-hospital use of anti-platelet drug was associated with lower minimum and maximum platelet counts that were reached at days 4 and 15, respectively.
In both non-surgery and surgery patients the use of anti-platelet drugs was associated with higher age (70±11 vs 58±20 and 70±13 vs 49±20, respectively) and APACHE II score (27±9 vs 21±9 and 24±9 vs 17±8, respectively). Use of anti-platelet drugs was also associated with an insignificant increase in transfusion-requiring bleeding in non-surgery and surgery patients (27% vs 14% and 69% vs 55%, respectively). Compared to patients without anti-platelet drugs, the use of antiplatelet drugs was associated with a slightly reduced mortality (40% vs 50%) in non-surgery patients and a slightly increased mortality in surgery patients (31% vs 24%), but the differences were not significant. However, in patients on anti-platelet drugs the predicted mortality rates calculated on the basis of the individual APACHE II scores was remarkably higher than the actual mortality rates (non-surgery patients 58±24%, surgery patients 48±26%). When matching patients (non-surgery and surgery) according to their individual APACHE II scores, the use of anti-platelet drugs was associated with a relative risk of mortality of 0.51 (95% CI 0.28 -0.85) in the 3rd quartile of APACHE II scores (21 -26) and 0.73 (0.58 -0.92) in the 4th quartile (> 26) of the scores.
Multivariate regression indicated that the use of anti-platelet drugs was a significant negative predictor of mortality in non-surgery as well as surgery patients (p<10-7 and p<10-3, respectively), whereas APACHE II and age were positive predictors of mortality.
Conclusion:
The use of anti-platelet drugs for secondary prevention of cardiovascular disease clearly decreased the mortality rate in both non-surgically and surgically ICU-patients. Therefore, anti-platelet drugs could be a novel therapeutic option to reduce organ failure in these patients.
059
Infection 2007 Introduction: Bioactive lipids such as ceramide (Cer) have significant effects on cells relevant for inflammation, which may therefore be regarded as candidate mediators in systemic inflammatory response syndrome (SIRS). In pts with sepsis, Cer concentration in mononuclear cells has been identified as a marker to predict multiple organ failure. In order to elucidate the role of Cer formation in the development and progression of systemic sequelae of SIRS, we addressed the question whether there is a difference in the sphingolytic activity of the secreted isoform of sphingomyelinases (pSMPD1) in plasma of pts with various degrees of SIRS or sepsis of different origin. Methods: Plasma samples were obtained from pts with SIRS after off pump coronary bypass surgery through a mini-left anterior thoracotomy (MIDCAB), after CABG using an extracorporeal circuit (cardiopulmonary bypass -CPB) as well as from patients with sepsis. Activity was determined by the hydrolysis of fluorescently labelled sphingomyelin, plasma presence of the enzyme was identified by immuno blotting. In endothelial cells exposed to plasma, we determined the sphingomyelin turnover and the resulting Cer pattern by chromatographical separation as well as the formation of Cer enriched macrodomains by fluorescence microscopy. Results: Plasma activity of sphingomyelinase (pSMPD1) in samples of pts with sepsis (median 262.3 pmol/(ml*h)) were higher than those of age matched controls (median 123.6 pmol/(ml*h); p < 0.005). In pts with fatal outcome (n=7) sphingolytic activity increased during the study period (+ 77.4 pmol/(ml*h)), while a decrease in the subgroup of sepsis survivors was observed (-252.1 p < 0.02). Low and high pSMPD1 activity levels were paralleled by equally low or high values of established clinical severity markers such as SOFA score or proCT value. Comparing the absolute increase of pSMPD1 activity 24 hours after either MIDCAB surgery or CABG with CPB we found the increase of enzyme activity to be significantly lower in both the MID-CAB group as well as in patients without SIRS at the first day post op. Beyond immunological detection of increased pSMPD1 in septic patients, we found an increase in breakdown of sphingomyelin in endothelial cells after stimulation with patients' plasma as well as endotoxin or prototypic pro-inflammatory cytokines such as TNF. Also we found formation of ceramide enriched macrodomains by immunostaining using specific antibodies directed against Cer, CD14, Fas-receptor and TNF-Receptor1.
Conclusion:
Here we demonstrate an increased pSMPD1 activity in pts with SIRS and sepsis. Together with data from in vitro experiments and animal models, the results provide the first demonstration of a bio-functional relevant activity of pSMPD1 resulting in an altered signal transduction in systemic inflammation. The association with sepsis related mortality suggests that increased pSMPD1 activity may be involved in the complex network of processes finally resulting in an unfavourable outcome. Introduction: Early specification of bacterial and fungal pathogens plays a crucial role in sepsis therapy. A new real real-time PCR system (SeptiFast ® , Roche Diagnostics, Mannheim) allows a more rapid identification for 25 of the most common pathogens compared to standard blood culture (BC). The test specifically targets the ITS -region of bacteria and fungi in 3 ml K-EDTA blood and can be completed in less then 6 h. Objective, Methods, Results: We were interested whether the new real time PCR System would indicate an advantage in early identification of common pathogens compared to standard BC. After approval of the study by the local ethic committee and having obtained informed consent, we included 21 Surgical Patients with severe sepsis and septic shock according to the S2 guidelines of the German Society of Sepsis. All Patients had significant elevated inflammatory parameters (PCT, IL-6, LBP) at study entry. Blood samples for PCR and BC were taken at admission to the anaesthesiological/surgical ICU and at up to six following time points, every 24 h. Samples were taken by sterile venous puncture or from the arterial line. Whenever possible, swaps were taken from suspicious sites fore completion of microbiological diagnostics. Samples were analysed by the Institute of Medical Microbiology. Results In total 134 paired blood samples were obtained from 21 patients. In 62 samples PCR were positive, and in 20 samples blood cultures (table1). In 4 positive BC`s the pathogen must be considered as contamination (CONS). In 10 samples PCR and BC detected the same pathogens. Additionally in 11 samples Pathogens detected by PCR were also identified by swaps. Table 3 , PCR detected pathogens at earlier time points than BC. Introduction: Persistent bacteraemia is indicative of an invasive infection that may lead to sepsis. Rapid administration of adequate antimicrobial therapy improves outcome. However, pathogen identification by conventional microbiological methods usually takes up to 36 h. Two-step nucleic acid based techniques comprising of an initial broad-range PCR followed by a separate pathogen identification step have been introduced. Objective: Our study evaluates a newly developed single step realtime PCR based method (SeptiFast) in a cohort of sepsis patients and patients prior to elective surgery without clinical or laboratory signs of infection and compares it to conventional blood cultures. Methods After approval of the local ethics committee and acquisition of written and informed consent of the patient or a legal guardian, patients fulfilling the ACCP/ SCCM sepsis criteria were included in the study. For each comparative analysis 20 mL whole blood was drawn for blood culture analysis using a BACTEC system according to the manufacturers recommendations and 3 mL whole blood was collected for PCR analysis using the SeptiFast system according to the manufacturers recommendation.
Results: 453 blood samples of 108 patients study patients and 206 blood samples of 103 control patients were compared to parallel blood cultures. SeptiFast resulted in 2 fold more positive findings (n=114) than blood cultures (n=58). In 40 of 58 positive blood cultures findings were identical to SeptiFast. The negative predictive value of SeptiFast against blood culture was 0.95; sensitivity: 0.69; specificity: 0.81. 18 samples of positive blood cultures showed different SeptiFast results. 13 of these 18 cases could be resolved by being not in the panel detectable by SeptiFast or being flagged as contaminations. In 206 samples of the control group no positive SeptiFast results were found. 22 blood culture findings were positive for CoNS, after prolonged culturing: these results were regarded as contaminations. SeptiFast results were also analyzed against a constructed microbiologic gold standard comprised of the presence of pathogens in blood cultures or other additional patient specimen (e.g. BAL, urine, swabs) taken on the same day as the SeptiFast sample. SeptiFast detected 74 pathogens, which were negative by blood culture findings. 51 of these 74 SeptiFast results matched with microbiologic results from additional specimen. This increased the sensitivity of SeptiFast compared to the constructed gold standard to 0.83; the specificity increased to 0.93; the negative predictive value was 0.95. Conclusion: Our study demonstrates concordance of PCR results with blood cultures. We confirmed increased sensitivity of PCR based diagnosis of bloodstream infection. Our results are indicative of potential clinical utility of PCR based pathogen identification. Studies addressing changes in clinical decision-making, outcome and cost-benefit by the utilization of PCR results are needed.
Infection 35 The ventilation strageties influence outcome in patients with severe sepsis -results from a national prospective multicenter study Objectives: The objectives of this study were to 1) describe the actual ventilatory strategies applied in the clinical practice, 2) analyse the association of the different ventilatory strategies with mortality and 3) identify the potential risk factors for death associated with the ventilator therapy and the respiratory system in patients with severe sepsis and septic shock.
Methods:
In the "Epidemiology of Sepsis in Germany" study, a prospective observational cross-sectional study, data from 454 intensive care units (ICU) in 310 randomly selected hospitals in Germany were collected by local one-day visits of trained physicians from SepNet's 17 regional study centres. Variables associated with the respiratory system and mortality were analysed in patients ventilated with PCV, VCV and AV as well as in patients classified as acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and non-ALI.
Multivariate analysis was applied to identify possible risk factors for death.
Results: In a cohort of 415 patients with severe sepsis, 20% did not need mechanical ventilation. Non-invasive ventilatory support was used in 5% of the ventilated patients, 32% were ventilated via tracheostoma, 63% were either orally or nasally intubated. Hospital mortality did not differ between PCV (57%), VCV (71%) and AV (51%) (p=0.23). Peak pressures above 35 cm H2O were associated with higher mortality rates (p=0.05) whereas there was no association between the tidal volume and hospital mortality (p=0.57). ALI occurred in 42% and ARDS in 27% of the ventilated patients. Significantly higher hospital mortality was found in patients with ALI (57%) and ARDS (69%) when compared with non-ALI patients (41%; p = 0.015). The estimated respiratory system compliance, renal dysfunction and APACHE II score were identified as independent risk factors for hospital mortality.
Conclusions:
In this study we did not find an association between the ventilatory strategy and mortality of patients with severe sepsis or septic shock. The combination of ALI and sepsis or septic shock significantly worsened the patients´ outcome. Introduction: The provision of an appropriate nutritional support is an accepted part of the standard intensive care in septic patients. Nonetheless, it is unclear whether the route of nutrition has an influence on the clinical outcome in this subgroup of critically ill patients.
Objectives: To describe current clinical practice of nutrition and evaluate its association with mortality in patients with severe sepsis or septic shock in Germany.
Methods:
In the "Epidemiology of sepsis in Germany" study, a prospective observational cross-sectional study, data from 454 intensive care units from a representative sample of 310 randomly selected hospitals in Germany were collected by trained physicians from the SepNet's 17 regional study centers during randomly scheduled one-day visits over a period of one year. 415 patients with severe sepsis or septic shock were identified (according to ACCP/SCCM consensus conference criteria). Data were evaluated concerning nutrition modalities. Logistic regression analysis was used to identify predictors for death.
Results: Valid data on nutrition were available for 399 of 415 patients. 20.1% of these patients received exclusively enteral nutrition while 35.1% were nourished exclusively parenterally. Mixed nutrition (parenteral and enteral) was administered to 34.6 % of patients, 10.3% were not fed at all. Patients with septic shock, mechanical ventilation or a possible contraindication to enteral nutrition were less likely to receive exclusively enteral nutrition. Median APACHE II score but not SOFA score was significantly different among the nutrition groups. Overall hospital mortality in septic patients was 55.2%. Hospital mortality was significantly higher in patients receiving exclusively parenteral (62.3%) or mixed nutrition (57.1%) than in patients with exclusively enteral nutrition (38.9%) (p = 0.005). By multivariate analysis, presence of parenteral nutrition (odds ratio, 2.09; 95% confidence interval, 1.29 -3.37), APACHE II score (odds ratio, 1.05; 95% confidence interval, 1.02-1.09) and renal dysfunction (odds ratio, 2.07; 95% confidence interval, 1.30 -3.31) were significantly predictive of mortality. Conclusions: Patients with severe sepsis or septic shock in German intensive care units receive preferentially parenteral or mixed nutrition. In this study, the use of parenteral nutrition was directly associated with an increased risk of death. Our aim was to evaluate 1,3-beta-D-glucan concentrations in plasma of critically ill patients with severe sepsis and SIRS. Methods: 26 patients with severe sepsis and 22 patients after coronary artery bypass grafting (CABG) were included in this pilot study. Plasma samples were collected daily in the sepsis group or on day 1 after surgery in the CABG-group. 1,3-beta-glucan was measured with a turbidometric assay (Wako Pure Chemical Inc.). A cut-off level of 11 pg/ml was used.
Results: 1,3-beta-glucan serum levels were elevated after uncomplicated CABG and differed significantly to the sepsis group (figure). Median concentrations were in the normal range in severe sepsis patients but fraction of elevated 1,3-beta-glucan serum levels tend to increase with length of stay. Conclusions: This first observational study demonstrated consistent results of serum 1,3-beta-glucan measurements in different populations of critically ill patients. Bacterial translocation has been suspected as reason for SIRS after CABG, however, this has never been associated with fungemia. This finding warrants further research. Introduction: The degree of systemic inflammatory reponse against bacterial invasion considerably correlates with the number of organ dysfunctions and amount of released mediators. We examined IL-6 levels in serious sepsis and septic shock at survivor and non-survivor patients. We analysed the cinetics of IL-6 and its relationship with PCT level. Patients: We randomised 13 patients with serious sepsis (3 organ failure) and 15 patients with septic shock. We identified pulmonal infection at 19 cases and intraabdominal infection at 9 cases as septic focus.
We measured IL-6 and PCT levels, counted APACHE-II and SOFA scores at the recognition of serious septic process (0h) and in the 6th, 12th, 24th, 48th and 72th hours. Results: We couldn't find any significant difference among 0h IL-6 levels. 6h IL-6 levels were significant higher at patients with septic shock. 12h IL-6 levels were pregnant decreased in both groups, although IL-6 levels remained higher at non-survival patients. We marked a peak of APACHE-II, SOFA score and IL-6 in the 6. hour. We detected over 10ng/ml PCT levels from 6th hour and decrease from 36th hour in both groups. Conclusion: IL-6 is suitable for estimation of sepsis severity and usable at diagnostics of septic shock. Its permanently higher level is a predictive marker of outcome. Case report: The toxic shock syndrome (TSS) is a high mortality desease. Pyrogen endotoxins generated by Staphylococcus aureus and Streptococcus pyogenes (TSST-1, SPEC, SPEA) effect excessive citokine production as superantigens stimulating the T-lymphocytes on non-specific way. TSS is clinically caracterized by rapid onset and procession, fever, shock and MOF. Early and adequate therapy determines the outcome of TSS. We compare Staphylococcus aureus and Streptococcus pyogenes TSS presenting two case reports (68 yrs old male and 48 yrs old female). We demonstrate criterias, diagnostic differences and therapeutical management according to CDC definitions. Although the incidency of the disease is considerably low, the importance of TSS is based on 1) the huge mortality, which compromises the healthy population, 2) the lack of natural immunity against virulency factors in public communities, 3) unchanged mortality in spite of modern diagnostical and therapeutical management. Introduction: Endotoxemia leading to endothelial activation and loss of vascular resistance by increased production of nitric oxide is an important factor in the development of distributive shock and multiorgan failure in septic patients. The removal of endotoxin from the circulation has thus been advocated as a treatment option in sepsis. We report the results of the first application of a novel Endotoxin adsorption column (ET-Adsorber, Gambro, Sweden) in septic patients. Methods: Patients were included if they met the following criteria: 2 or more SIRS criteria, a plasma-endotoxin concentration of 0,1 EU/ml in the chromogenic Limulus Amebocyte Lysate (LAL) test, a clinical indication for the placement of a dialysis catheter. Plasma separated from blood in a plasma filter and pumped through the adsorption column made of a hydrophilic vinyl copolymer with an arginine ligand, and then returned to the blood stream. Five treatments per patient were performed on consecutive days. Clinical and laboratory, as well as hemodynamic data were recorded and values before and after treatment sessions were compared. Results: Ten consecutive patients were included (8m, 2f, age 56.2 ± 10.7 years). They had sepsis resulting from nosocomial pneumonia (n=3), spontaneous bacterial peritonitis (n=2), soft-tissue-abscesses (n=2), peritonitis (n=2) and without obvious focus in one case. Initial APACHE II score was 29.7 ± 8.7, and the mean SOFA score before the first treatment was 14.5 ± 4.5. Plasma-endotoxin before the first treatment had a median of 0.70 EU/ml (range: 0.11 -2.4). Hospital mortality was 40%. 49 treatment sessions were performed. Comparing measurements before and after adsorption treatments, mean arterial pressure increased from 80.76 ± 15.7 mmHg to 88.16 ± 16.7 mmHg and cardiac power index from 0.72 ± 0.22 to 0.81 ± 0.22 while norepinephrine (NE) could be reduced from 4.0 (0 -29)µg/min to 2.2 (0-29)µg/min. There was an increase in Global Enddiastolic Volume Index (GEDVI) from 744.6 mL m-2 to 784 mL m-2. In between treatments, changes were partially reversed. Changes in Cardiac Index (CI), and Systemic Vascular Resistance (SVRI) were not significant. Proapoptotic activity of plasma and the amount of advanced oxidation protein products decreased during the adsorption treatments but there was no change in reactive carbonyl compounds. There were no complications attributable to catheters or extracorporeal circulation.
Conclusion:
In septic patients with endotoxin adsorption the dose of vasopressors could be significantly reduced while MAP levels increased suggesting an improved vasotonus and improved myocardial contractility. The treatment appears to be save and efficient and randomized studies should be performed. 21, 9) , PL 37,6 pg/ml (20,2-55,0), R 32,9 (21,9-44,0), NR 39,9 (17,1-62,6); IL6/IL10-ratio: HC 46, 6 (23, 4), PL 43, 6 (25, 0), R 45, 2 (27, 6), NR 44, 9 (17, 2) . Mean changes from baseline were: IL6: HC -38% (D3) and +4% (D6), PL +44% (D3) and +105%, p<0.005; IL10: HC +82% (D3) and +106% (D6), PL +84% (D3) and +239% (D6), n.s.; IL6/IL10-ratio: HC -23% (D3)and -12% (D6), PL +102% (D3)and +33% (D6), p<0.05; Within the HC-group, changes from baseline were not significantly different between R and NR for all parameters. Within the PL-group, IL6/IL-10-ratio decrease was significantly higher in NR (p<0.05) whereas no differences could be observed for other parameters. 3) concern about the use and accuracy of glucometers and 4) strategies for optimal glucose management. We used the same selfadministered format with binary answers of yes/no and ten-point scales of 1 mmol/l increments for glucose values. The questionnaire was sent to 17 ICUs of regional SepNet centers. Participation was voluntary. Answers depicted "nurse", "resident" or "attending physician", but were otherwise anonymous. The survey was conducted from October 2005 -January 2006. Results: Questionnaires were returned from 342 nurses, 98 residents and 34 attending physicians. Nurses and residents reported to feel concern about hypoglycemia from 3.0 mmol/l (median, IQR 3-4 mmol/l) downwards, consultants reported a threshold of 3.5 mmol/l (3.0-4.0 mmol/l). Hyperglycemia in non-diabetic patients was a concern from 8.0 mmol/l upwards (8.0-9.0 mmol/ l for nurses, 8.0-10.0 mmol/l for residents, 7.0-8.0 mmol/l for attending physicians). The threshold for hyperglycemia in diabetic patients was reported by residents and attending physicians as 8.0 mmol/l (8.0-10.0 mmol/l for residents, 8.0-8.75 mmol/l for attending physicians) and by nurses as 9.0 mmol/l (8.0-10.0 mmol/l). When asked for conditions in which patients would benefit most from glycemic control, attending physicians most often named stroke and heart surgery, residents named stroke and sepsis, and nurses sepsis and diabetes. Nearly all diseases in question except diabetes were rated with varying degree of importance by the different members of the ICU health care team. Strategies to improve glycemic control were also rated variably.
Conclusion
Conclusions:
This survey in German ICUs shows that attitudes and belief on the practice of glycemic control differ widely among nurses, residents and attending physicians. Generally, attending physicians reported tighter blood sugar thresholds, perceived more benefit in given disease conditions and asked for more frequent measurements, reminders and i.v. insulin therapy than residents or nurses. Introduction: Apoptosis and related forms of cell death have been suggested to contribute to a dysregulated immune response in shock and sepsis while their role in the development of end organ failure is discussed controversially. Methods: For a systematic evaluation of an activation of distinct cascades of apoptotic signaling, we analyzed serum levels of members of the TNF/TNFR family and the caspase cleavage product cytokeratin-18 neoepitope (CK-18) in patients with SIRS (n=49) or sepsis (n=38), which were subsequently correlated to disease severity. Results: Serum concentrations of markers of the TNF/TNFR family were higher in infectious as opposed to non-infectious systemic inflammation, albeit only sFas was increased above while sFasL and TRAIL levels were below levels observed in healthy volunteers. Increased serum levels of the caspase-3 cleavage product CK-18 were restricted to overt multi organ failure. A detailed exemplary analysis of apoptotic signaling correlating with liver dysfunction revealed a similar restriction of CK-18 release to most severe forms of liver failure along with the appearance of cytochrome c, but lack of sFasL in serum indicative of hepatocellular apoptotic injury via the intrinsic / mitochondrial pathway. Conclusion: Our data are consistent with effective protection of solid organs against apoptotic injury in mild and moderate organ dysfunction while programmed cell death seems to contribute to overt organ failure, e. With the increasing number of survivors the long-term quality of life becomes more and more an issue. ICU treatment is associated with physical and psychological stress. In some patients this stress leads to the development of posttraumatic stress disorder (PTSD) (1). PTSD and depression were assessed in long-term survivors of sepsis. Methods: 63 patients were approached who survived severe sepsis or septic shock (ACCP/SCCM) on our ICU. 2 screening instruments were used: for assessment of PTSD the IESR (Impact of Event Scale, Revised) was used, consisting of the three sub-scales 'intrusion', 'avoidance' and 'arousal'. The IESR is event independent, therefore patients were asked in the introduction to describe the most aggravating events they experienced on the ICU. For screening of depression the ADS (Allgemeine Depressions Skala) was applied.
Results: 36 patients, 25 males,11 females returned the questionnaires. Mean age was 63 ± 16 years. The median follow-up time was 2 years after discharge. In the IESR mostly mentioned as traumatising events were nightmares, helplessness and dependence from staff, and pain. Subjects were asked to answer the IESR with regard to these most traumatising events. 24 subjects filled in the IESR. Subjects with a positive score above 0.0 are likely to suffer from PTSD. 5 patients (20.8%) achieved positive scores. Neither age (t-test: p=0.393) nor gender (Chi2 test, p=0.608) had an influence on the results. 29 patients returned the ADS. The cut-off score for depressive symptoms is 16, with increasing scores pointing out increasing intensity of symptoms. 62% (24 patients) scored 16 or higher. 5 patients (17%) had scores from 16-20, 10 patients (35%) scored from 21-30, and 3 patients (10%) scored higher than 30. Neither age (t-test, p=0.623) nor gender (Chi2 test, p=0.197) had an impact on the result. Discussion: 20% of the observed sepsis survivors are likely to suffer from PTSD. As the IESR is only a screening instrument, clinical interviews would be necessary to confirm this diagnosis. The ADS scores show that many patients who underwent treatment in our ICU suffer from depressive symptoms. Again, to support this diagnosis, clinical interviews would be required. Recent publications support these findings (2). The median follow-up time of 2 years suggests that both PTSD and depression are already in a state of chronification. It remains unclear whether the subjects were burdened with depressive symptoms already before their admission to ICU. However, with regard to PTSD the symptoms could be attributed to the ICU stay, as the subjects filled in the IESR considering the events during their stay.
Conclusion:
In a screening survey of sepsis survivors 20% indicated symptoms of PTSD, 62% displayed acute depressive symptoms. To prevent chronification of these psychiatric disorders early psychotherapeutic treatment should be available for ICU. Reference: Critical Care (2007) In patients with sepsis a precise neurophysiological diagnosis allows to specify the early symptoms of disease within muscle and nervous system, monitoring its progress and directing towards treating as well as exposing additional injuries not linked to the sepsis itself. Effects of sepsis were differently described as evoking symmetrical miogenic rather than neurogenic changes in more proximal than distal muscles. Sepsis originated polyneuropathy was defined as symmetric abnormalities expressed in distal parts of motor and sensory nerve fibers. Observed in the sepsis changes are mostly axonal, with the greater expression in the sensory fibers. Little attention was paid to the advancement of this disease and pathological disturbances accompanied by the patients age related alterations in the functioning of the nervous system. This study concerns three cases of advanced sepsis in patients aged 14, 22 and 48 years treated more than three months. Besides neurological examinations, neurophysiological tests including electromyography (EMG), electroneurography (ENG; M, F and H-wave studies as well as sensory conduction studies-SCV) within upper and lower extremities has been performed. Our findings shows the picture of changes in the muscle motor units activity and nerve transmission as depending primarily to the patient age with minor influence of the sepsis advancement. Miogenic changes can be found in muscles only within 1 month after beginning of the incident, later (usually after 2 months) they are preferably neurogenic and they can be clearly seen only in distal muscles. Sensory disturbances are early, serious and constant both in proximal and distal parts of extremities. Demyelinating than axonal symmetrical changes were mainly found in distal parts of motor fibers. Result of neurological examinations exactly overlap with neurophysiological findings. patients with acute kidney injury were randomized to receive either SED dosed to maintain plasma urea levels between 20-25 mmol/l, or IED dosed to maintain plasma urea levels near-normal (<15 mmol/l). In the latter group patients received at least two daily treatments within the first 2 days after initiation of RRT. We used the same dialysis system (Genius™) and high-flux polysulphone dialyzers for all RRTs. The outcome measures were survival at day 14 (primary), and survival and renal recovery (RR), as defined by no need of RRT at day 28 (secondary) after initiation of RRT. Results: Before the sepsis bundles were introduced, performance was inadequate regarding fast application of a broad spectrum antibiotic, obtaining blood cultures, and implementation of our ICU policy checking the indication for drotrecogin alfa (activated). All three items were improved after implementation of the SOP while maintenance of blood glucose levels decreased after SOP introduction. There was no difference in outcome between the two groups. Data are expressed as frequencies or median (25%, 75% percentile). Conclusion: Assessment of quality of care with tools such as the Chart Review Database can identify shortcomings in the care of sepsis patients. Implementation of the sepsis bundles improved performance in items identified as inadequate. Introduction: The pathogenesis of endotoxemic tubular dysfunction with failure in urine concentration is poorly understood. Urea plays an important role in the urinary concentrating mechanism and expression of the urea transporters UT-A1, UT-A2, UT-A3, UT-A4 and UT-B is essential for tubular urea reabsorption.
Objective: The present study attempts to assess the regulation of renal urea transporters during severe inflammation in vivo. Methods: By agreement of the animal protection committee C57BL/6J, mice were injected with lipopolysaccharides (LPS, 10 mg/kg) or proinflammatory cytokines. Hemodynamic, renal parameters and the expression of renal urea transporters were investigated. To clarify the role of cytokines and renal ischemia in the regulation of renal urea transporters, experiments with cytokine knock-out mice, mice treated with low dose LPS (1,5 mg/kg) as sepsis model without induction of hypotension, glucocorticoid-treated mice, and mice with renal artery clipping serving as model for renal ischemia were performed. Results: LPS-injected mice (10 mg/kg) presented with reduced GFR, fractional urea excretion and inner medulla osmolality associated with a marked decrease in expression of UT-A1, UT-A2, UT-A3, UT-A4 and UT-B. Similar alterations were observed after application of TNF-alpha, IL-1beta, IFN-gamma or IL-6. LPS-induced downregulation of urea transporters was not affected in knockout mice with deficient TNF-alpha, IL-receptor-1, IFN-gamma or IL-6. Glucocorticoid treatment inhibited LPS-induced increases of tissue TNF-alpha, IL1beta, IFN-gamma or IL-6 concentration, diminished LPS-induced renal dysfunction and attenuated the downregulation of renal urea transporters. Injection of low dose LPS (1,5 mg/kg) also led to renal dysfunction paralleled by a downregulation of renal urea transporters without alterations in blood pressure. Renal ischemia induced by renal artery clipping did not influence the expression of urea transporters.
Conclusion: Our findings demonstrate downregulation of renal urea transporters which likely accounts for tubular dysfunction during sepsis and suggest that downregulation of renal urea transporters during LPS-induced ARF is mediated by proinflammatory cytokines and is independent from renal ischemia due to sepsis-induced hypotension. Furthermore, our results contribute to understand the failure of single anti-cytokine strategies on one hand and the beneficial effects of glucocorticoids on the other hand in the therapy of septic patients. Acknowledgements: The study was supported by grants from the German Research Foundation (SFB 699; B3/B4). Introduction: Since Drotrecogin alfa (activated) (DAA; recombinant activated Protein C) was introduced for therapy in severe sepsis several mechanisms on the mode of action were discussed. Yet, some effects were investigated only in cell culture [1] . Recently, anti-apoptotic effects of DAA were shown on circulating mononuclear cells of septic shock patients [2] . Caspase activation may directly alter cell function of cardiomyocites. A possible relationship between endotoxin-induced caspase activation and reduced contractile reserve was described [3] . However, a direct effect of DAA on solid organ tissue in-vivo is not described. Objective: To investigate whether there is an effect of DAA on Caspase-3 in myocardial tissue in a murine model of sepsis. Methods: Male NMRI-mice (n=21, body weight 30±3g) were randomized to sham-treatment, sepsis by cecal ligation and puncture (CLP) and vehicle infusion, or CLP sepsis with DAA infusion (24µg/ kg/hr). 48 hrs prior to CLP all mice were given a permanent i.v.-line (self-made) and an arterial transmitter (PA-C10, St. Paul, MN, USA) to measure heart rate (HR) and mean arterial pressure (MAP). Activity was recorded by scoring from 1 (healthy) to 5 (agony) [4] . CLP was adjusted to survive 24 hrs. All mice were killed 12 hrs after CLP after scoring, and recording of vital data. Hearts were fixed in formalin and embedded in paraffin. Immunohistochemical analysis of the paraffin sections was performed using the avidin-biotin-peroxidase-complex (ABC) method. For Caspase-3 analysis a rabbit polyclonal anti-Caspase-3 Cleaved antibody (CPP32, Zytomed, Berlin, Germany) was
Pathophysiology
Infection Objective: The aim of our study was to compare the direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in the isolated septic rat heart. Methods: Polymicrobial sepsis was induced in male Wistar rats (220-250 gr.) via cecal ligation and single puncture (CLP, n=40). After 20 hours of incubation hearts were isolated and retrograde perfused at constant pressure (55 mmHg) in Langendorff apparatus. After stabilization the hearts were randomly assigned by lottery to four groups (10 hearts each) and received dopamine, dobutamine, epinephrine or levosimendan at concentrations of 10 -9 to 10 -3 M with one of these drugs for a period of 15 min followed by a drug-free washout period. Mechanical performance (LVP: left ventricular pressure, +dp/dt: contractility, -dp/dt: lusitropie) and heart rate (HR) were recorded. O 2 tension, electrolytes, and lactate in the coronary outflow were measured to determine oxygen delivery (DO 2 ), percentage oxygen extraction (O 2 Ext), myocardial oxygen consumption (MVO 2 ), and cardiac efficiency. Raw data from each functional and metabolic variable were compared by analysis of variance (ANOVA) wit h repeated measures. P<0.01 was considered to be statistically significant.
Results:
Except for levosimendan, all tested drugs showed over a range from 10 -9 to 10 -3 M concentration dependent significant positive chronotropic, inotropic and lusitropic effects. Dobutamine, dopamine, and epinephrine increased maximal HR (21, 26, 30%, respectively), +dp/dt (187, 194, 260%, respectively) , and -dp/dt (202, 211, 244%, respectively). This was accompanied by an increase in MVO2 (118, 113, 142%, respectively), and an adequate gain in coronary flow (56, 62, 50%, respectively). Levosimendan, only showed a trend towards a positive intropic effect, but this was not significant. Although, this was accompanied by a significant increase in MVO2 (47%). High concentrations of dobutamine (>10 -5 M), dopamine (>10 -3 M), epinephrine (>10 -6 M), and levosimendan (>10 -5 M) showed negative chronotropic and inotropic effects. Discussion: Dobutamine, dopamine und epinephrine showed a dose dependent increase in heart rate, left ventricular pressure, contractility and relaxation in the isolated septic heart. In contrast, an improvement of cardiac performance in septic depressed heart via a short-term intervention with levosimendan showed no beneficial effect in this model. Objective: The aim of our study was to compare the direct cardiac effects of ketamine and propofol in the isolated septic rat heart. Methods: Polymicrobial sepsis was induced in male Wistar rats (220-250 gr.) via cecal ligation and single puncture (CLP, n=20). After 20 hours of incubation hearts were isolated and retrograde perfused at constant pressure (55 mmHg) in Langendorff apparatus. After stabilization the hearts were randomly assigned by lottery to two groups (10 hearts each) and received ketamine or propofol at concentrations of 10 -7 to 10 -4 M with one of these drugs. Mechanical performance (LVP: left ventricular pressure, +dp/dt: contractility, -dp/dt: lusitropie), and heart rate (HR) were recorded. O 2 tension, electrolytes, and lactate in the coronary outflow were measured to determine oxygen delivery (DO 2 ), percentage oxygen extraction (O 2 Ext), and myocardial oxygen consumption (MVO 2 ), and cardiac efficiency. Raw data from each functional and metabolic variable were compared by analysis of variance (ANOVA) with repeated measures. P<0.05 was considered to be statistically significant. Results: Propofol and ketamine showed over a range from 10 -7 to 10 -5 M concentration dependent no significant effect on LVP, +dp/dt or HR. But propofol showed at 10 -4 M significant negative inotropic (LVP: -30%; +dp/dt: -38%) and chronotropic (-29%) effects. This was accompanied by a reduction in MVO 2 of 16% at 10 -4 M. Ketamine only showed a slight but significant reduction in HR (-14%) at 10 -4 M compared to control values. Even though this reduction was to a lesser extent compared to propofol at equimolar concentration (10 -4 M). Discussion: Propofol, but not ketamine showed significant dosedependant negative inotropic as well as chronotropic effects at concentrations >10 -5 M in the isolated septic heart. Septic depressed heart function might deteriorate with these high plasma concentrations of propofol achieved by bolus administration or long-term infusion (Kim 2007) in sedated patients in severe sepsis or septic shock, especially in case of multiple organ failure accompanied by a decreased hepatic and renal metabolism. Ketamine showed at concentration from 10 -7 to 10 -4 M a safe administration regarding influence on inotropic performance in septic rat heart. Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs
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Introduction: HES is one of the most frequently used plasma substitutes. A variety of different HES solutions exist worldwide, which differ greatly in their pharmacologic properties. Objective: To determine the differential influence of molecular weight and the degree of substitution of HES solutions on pharmacodynamics and pharmacokinetics including organ storage in a model of acute hemodilution in pigs. Methods: After bleeding, 20ml/kg, animals were substituted with 6% HES preparations (200/0.62, 200/0.5, and 100/0.5). Quantitative analysis of HES concentrations in body fluids (plasma, urine) was performed and samples of liver, spleen, kidney, lung and lymph nodes were extracted. Results: We did not observe any significant differences in the ability to sufficiently achieve plasma volume expansion and restoration of macrocirculation, nor maintenance of indicators of microcirculation between the groups. Urine production was significantly higher in HES-treated animals and highest in animals substituted with HES 100/0.5. Plasma clearance was measured under steady-state conditions with significantly reduced clearance for the HES 200/0.62 group compared with HES 100/0.5 and HES 200/0.5 (6.6 vs. 13.2 and 13.9ml/min; P</=0.001), thus being dependent on the degree of substitution. Even after only 6h, the amount of infused HES not detectable in either blood or urine was significantly higher in HES 200/0.62-treated animals (50.7% compared with HES 200/0.5 (28.8%), P=0.020 and HES 100/0.5 (28.4%), P= 0.018), with its proportion rising over time. Finally, we could demonstrate considerable amounts of all HES solutions being stored in liver, kidney, lung, spleen and lymph nodes. Conclusion: All preparations analyzed sufficiently restored macroand microcirculation; however, for all solutions relevant tissue storage of HES was observed after only 6h. Introduction: Monocyte/macrophage desensitization is a marker of the hypo-inflammatory phase of sepsis. We propose that alternative macrophage activation in response to phagocytosis of apoptotic cells (POAC) is one mechanism provoking an anti-inflammatory macrophage phenotype, thus causing immune paralysis. Using RAW 264.7 mouse macrophages which have been retrovirally transduced with a dominant negative PPARgamma1 mutant we demonstrated recently that inhibition of the oxidative burst in response to POAC is PPARgamma dependent. Because it is well known that PPARgamma dominant negative mutants also affect signaling by other PPARs such as PPARalpha and PPARbeta/delta, it is our intention to generate a PPARgamma conditional knockout mouse system. Thus, PPARgamma expression should be knockedout in primary murine macrophages, to finally verify a PPARgamma-dependent mechanism in primary cells. Objective: Verification of PPARgamma-dependent macrophage desensitization using primary PPARgamma knock-out macrophages derived from spleen of conditional PPARgamma knockout mice. Methods: mxCre PPARgammafl/fl mice were treated i.p. for 1 week with pIpC [250 µg/mouse] at day 1, 4, and 7 to induce PPARgamma deletion in leukocytes. MACS separation for CD11b-positive cells from spleen suspensions was performed using an autoMACS. Enrichment was verified by FACS analysis. Deletion of PPARgamma was verified using genomic DNA-and RT-PCR. For ROS detection cells were divided into 4 FACS tubes/mouse. For 1 h the PPARgamma agonist rosiglitazone [10 µM] was added to tubes 1 and 2, whereas tubes 3 and 4 remained as controls. After 1 h PMA [1 µM] was added to tubes 1 and 3 and incubation continued for 30 min. Afterwards, 20 nM of the redox-sensitive dye hydroethidine was added to all samples for 20 min. ROS production was determined by FACS analysis. In addition, cytospins were performed to follow PKCalpha localization. Results FACS analysis in PPARgamma negative cells revealed no alteration of PMA-elicited ROS production after adding the PPARgamma agonist rosiglitazone. In line in spleen derived macrophages of control mice, expressing PPARgamma, PPARgamma activation inhibited PMA-mediated ROS production. Moreover, PKCalpha translocation was analyzed as well in this experimental setup. We noticed that PKCalpha translocation was restored in PPARgamma knockout macrophages whereas translocation was inhibited in control cells.
Conclusion:
In primary spleen derived mouse macrophages activation of PPARgamma provokes desensitization by inhibiting PMA mediated ROS formation. Superoxide production was restored in PPAR-Pathophysiology gamma knockout macrophages derived from spleens of conditional PPARgamma knockout mice. Taking these data into consideration we propose, that PPARgamma mediated alternative macrophage activation in response to phagocytosis of apoptotic cells, which is a marker of sepsis. This might be important for sepsis progression. Introduction: Sepsis is a leading cause of death among critically ill patients. It is characterized by infectious origin, systemic inflammation and organ dysfunction. Cecal ligation and puncture (CLP) with subsequent bacterial peritonitis is a common way of inducing sepsis in rodents. However, sepsis progression in the CLP model is slow. Up to this date, severe sepsis with acute onset in animals has been induced mainly through intraperitoneal (i.p.) or intravenous (i.v.) injection of single bacteria species or endotoxin. It has been argued, however, that these models are somewhat artificial and do not adequately mirror the situation in septic patients on ICU. Objective: We therefore aimed to establish an animal model of severe sepsis characterized by acute onset and high mortality based on the widely accepted CLP model. Methods: After governmental approval of this prospective randomized study, 28 male Sprague-Dawley rats (we ight 527[17] g, Median[Semi-Inter Quartile Range], Rank Sum Test) were anaesthesized by i.p. injection of pentobarbital/fentanyl (p/f). Following tracheotomy, rats were mechanically ventilated. Anaesthesia was maintained by i.v. infusion of p/f. After baseline arterial blood gas analysis (BGA), the cecum was exteriorized through midline laparatomy. In the SHAM-group (14 rats), the cecum was replaced into the abdomen after gentle manipulation. In the other group (14 rats), the cecum and the mesenteric blood vessels were ligated below the ileocecal valve. The cecum was opened through a blade incision on the anti-mesenteric side (cecal ligation and incision, CLI). Subsequently, the cecum was replaced into the abdomen. The abdominal wall was closed in two layers in both groups after i.p. fluid resuscitation. Mean arterial blood pressure (MAP) and BGA were measured hourly for 6.5 h. At the end of observation time or in case of prior death, plasma samples (for ELISA), peritoneal l avage (for cell count), and abdominal swabs (for bacterial culture) were obtained. cells/ml*. Abdominal swabs from SHAM-animals were sterile on agar and showed E. faecalis, P. mirabilis and E. coli growth in the CLIgroup. Conclusion: Bacterial growth proved the infectious origin in this animal model. Systemic inflammation was present in CLI-animals as indicated by an increase in IL-1β and IL-6 plasma levels and by leukocyte migration into the peritoneum. Organ dysfunction in CLI-animals was reflected by a decrease in MAP, BE, and pH. Thus, we have successfully established an acute onset model of severe sepsis in rats by CLI, which will provide the base for future experimental studies. Introduction: The mouse model of sepsis offers extensive possibilities to study pathophysiological principles. Moreover, the use of genetically engineered animals enables us to accomplish the bridging from molecules to physiology. Transgenic mice harbouring well described particular defects of signaling pathways provide a tool to investigate immunological and physiological functions of these pathways during critical diseases like sepsis. Objective: The murine sepsis models, such as CLP, need to be carefully and well-characterized regarding pathophysiological changes over time. For this purpose, techniques are needed which are as little invasive as possible. We therefore examined respiratory parameters of unrestrained septic animals in order to correlate respiratory changes with the severity of sepsis. Methods: Respiration of unrestrained adult female C57BL/6 mice was measured using a whole body plethysmograph. Upon isoflorane anesthesia induction CLP surgery (double puncture with 18G-, 20G-, 22G-, 26G-needles) and laparotomy only (Sham) was performed in 4-8 mice for each group. Subsequently, mice received 1ml 0.9% NaCl s.c. once and buprenorphine 25ng/g s.c. twice a day. Minute volume (MV), tidal volume (TV) and breathing rate (f) were detected for 30 min after the operation followed by recurrent measurements every 12 hours for 5 days. Results: Basic parameters: MV 1,9 ± 0,2 ml/min/g, TV 6,1 ± 0,3 µl/g, f 237 ± 75 /min. The 5-day-mortality rate of the 5 groups was similar to studies performed earlier in our lab. (Sham: 0%, 26G: 16%, 22G: 25%, 20G: 37%, 18G: 100%). Post-op all groups showed similar respiratory parameters. At 12hrs after CLP MV in the 18G-and 20G group was decreased by 70 % and 35%, respectively. Interestingly, only those animals in the 20G-group that survived showed an increase of MV at 24h and 48h after CLP. The other groups demonstrated inconstant respiratory parameters. Thereafter, 20G-, 22G-, and 26G-treated mice showed similar reduced MV compared to sham mice, which exhibited normal values from 72hrs post-surgery on. From 84hrs on all surviving CLP mice started to increase their MV and fully recovered at 120hrs. Interestingly, the pattern of respiratory frequency closely resembled the course of MV in all groups throughout the observation period. TV did not show clear differences betwe en the groups. It has to be noted that telemetric observation of 22G-and 26G-mice revealed that their over-all activity is suppressed for 72hrs upon sepsis-induction.
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Conclusion:
This technique provides a suitable tool to study the spontaneous course of respiration during murine sepsis. MV is mainly determined by changes of f and not TV. Especially during the early period severe grades of sepsis are indicated by reduced MV which possibly indicates fatal outcome. Presumably, increased activity after 72hrs leads to enhanced oxygen consumption and, hence, to increased MV. At this time, surviving septic mice appear to recover from this disease. (HMG-CoA) reductase they display pleitrophic immune effects. A lack of HLA-DR (human leukocyte antigen), a component of the major histocompatibility complex (MHC) class II inhibits monocyte function which is a crucial event in immunosuppression during sepsis.2. Possibly, statins act as anti-inflammatory agents.
Objective: The objective of our study was to test if statins affect the constitutive expression of HLA-DR on monocytes. Methods: Monocytes of healthy subjects (with approval of the ethics committee) and the monocyte cell line Mono Mac 6 (MM6) were incubated with statins (simvastatin, mevastatin, pravastatin, lovastatin and fluvastatin) as well as mevalonate and their influence on MHC class I (HLA ABC) and class II (HLA-DR1) was observed by flow cytometry after 24h. To characterize possible mechanisms, the expression of CD74 (invariant chain) cathepsin S, interleukin 10 and its receptor, annexin V binding and caspase-3 activation were analyzed. mRNA expression was quantified by real-time rtPCR. ANOVA was used for statistical analysis. results. Results: Monocyte HLA-DR was downregulated by simvastatin at 500 nM (-13.51±4.02%, p<0.05) with increasing potency up to 20 µM (-26.86±8.35 %, p<0.01). mevastatin, pravastatin, lovastatin and fluvastatin downregulated HLA-DR as well (p<0.05). The expression of MHC class I instead was not affected by statins. Mevalonate, the product of HMG-CoA reductase can overcome the inhibition of the pathway. In the presence of mevalonate, simvastatin did not affect HLA-DR expression. Investigating possible mechanisms we analyzed induction of apoptosis by statins. While statins indeed induced apoptosis in MM6 cells, as confirmed by annexin V and caspase-3 staining, HLA-DR downregulation could be observed in the non-apoptotic annexin V and caspase-3 negative populations. Statins did not induce IL-10 production and did not change IL-10 receptor expression. mRNA expression of HLA-DR was not inhibited by statins. Therefore, a post transcriptional mechanism was suspected. Introduction: Severe sepsis is a serious complication following trauma, major surgery or infectious diseases. Little is known about genetic background which influences the susceptibility to severe sepsis. Human beta-defensins expressed by epithelial cells and peripheral white blood cells are cationic antimicrobial peptides, which also display modulating effects on other immune cells. Protein levels in plasma are detectable in patients with severe sepsis. Recent studies identified that the genes coding for human beta-defensin 2 (DEB4), human betadefensin 3 (DEFB103) and human beta-defensin 4 (DEFB104) showed variation in copy number. The effects of beta-defensins in immune system predestine beta-defensins genes to be candidate genes for genetically determined interindividual differences in host defence against invading pathogens.
Objective: This study investigated the association of human beta-defensin 4 gene copy number variation with the susceptibility to severe sepsis. Methods: 265 patients with severe sepsis and 231 healthy individuals were enrolled in the study. DNA was extracted from peripheral blood. Gene copy number was quantified by using real-time quantitative PCR.
Results: There are one-to four-copy number variants of human betadefensin 4 gene among patients and healthy controls. The frequencies of copy number variants are not significantly different between sepsis group and control group (p =0.294, chi-square test).
There is no association of copy number variation of human beta-defensin 4 gene with the susceptibility to severe sepsis in this study. A larger case-control study may be required to achieve adequate statistical power. Introduction: Cardiac remodeling is relevant in cardiovascular diseases and in heart failure (HF). It is widely accepted that pro-inflammatory cytokines play a major role in the development of HF, but few is known about the role of anti-inflammatory cytokines. Interleukin IL-13 is an anti-inflammatory cytokine secreted predominantly by activated Th2 cells. A recent report shows that IL-13 and IL-4 are markedly increased during various cardiac diseases. Moreover, an IL-13 receptor, IL-13R 1 as well as IL-4R are markedly expressed on human cardiac muscle cells. However, the meaning of these cytokines was only considered in respect of activation of immune cells in the development of heart diseases.
Methods:
The purpose of the present study was to determine survival effects of anti-inflammatory cytokines on cultured cardiac myocytes, if modulated by IL-4 or IL-13. Parameters of description were cell size, survival, protein synthesis, ATP content and myofibril development. Leukemia inhibitory factor (LIF) was used as a control as this Il-6 class is considered to exert hypertrophic as well as survival effects. Results: For the first time marked increases in protein synthesis, ATPcontent and number of surviving cells induced only by Il-13 but not by IL 4 could be demonstrated in cultured myocardial cells. In contrast to leukemia inhibitory factor (LIF), which served as a control, the elevation in protein synthesis was rather due to an improved viability in IL-13 treated cells. The signal transduction pathways regulating this induction were investigated. Activation of Akt, Janus kinases (JAK), signal transducer / activator of transcription (STAT 6) and cAMPindependent pathways were shown to modulate the cell function. 
The small bowel was isolated in female Wistar rats (body weight: 220-250 g). Cannulas were inserted into the proximal and distal small intestine as well as into the aorta close to the superior mesenteric artery and portal vein. The totally isolated organ was then transferred into a specially designed temperature-controlled, moist chamber with a built-in weighing system. The bowel weight was continuously measured as no organ bath was used. Ileal compatible medium enriched with glutamine, glucose and lactose was used for luminal bowel perfusion at a rate of 0.15 ml/min. Vascular perfusion was performed with modified oxygenated Krebs-Henseleit buffer in a flow-controlled mode at a rate of 7.5 ml/min. Fluorescein isothiocyanate (FITC) albumin and norepinephrine were added to the vascular perfusion medium. Vascular and intraluminal pressures and flows were continuously recorded. Lymphatic vessels were opened and the lymphatic fluid collected allowing the quantification of lymphati c fluid production. Variations in FITC albumin content added to perfusion media allowed the characterization of fluid fluxes among different compartments. After the establishment of the model based on experiments on 180 rats, an initial experimental series testing the effect of platelet activating factor (PAF) on intestinal function was performed on 8 rats.
Results: In this new model, vascular, luminal and lymphatic flows, arterial, venous and intraluminal pressures and bowel weight can be monitored simultaneously. The initial experiments revealed that the bowel was vital and stable for at least 140 min. This was confirmed by histological techniques and by measuring the oxygen and glucose consumptions as well as the lactate-to-pyruvate ratio. The first experiments with administration of PAF showed vasoconstriction and a shift of fluid from vessels to the luminal compartment while generation of lymph was increased for a short time period of about 10 min. This indicates a rise in permeability evoked by PAF comparable to former findings in the isolated lung (2).
Conclusion:
The presented model of an isolated perfused small bowel allows the separation of the vascular, luminal, extracellular and lymphatic compartments. We expect the model to be suitable for establishing the molecular mechanisms of bowel oedema formation. Methods: Sepsis was induced by cecal ligation and puncture (CLP) in male NMRI-mice (n=20, body weight 30±3g). Animals were randomly assigned to vehicle infusion, or CLP sepsis with DAA infusion (24µg/ kg/hr) or CLP sepsis with EA infusion (50µM). 48 hrs prior to CLP all mice were given a permanent i.v.-line (self-made) and an arterial transmitter (PA-C10, St. Paul, MN, USA) to measure heart rate (HR) and mean arterial pressure (MAP). Activity was recorded by scoring from 1 (healthy) to 5 (agony) [3] . CLP was adjusted to survive 24hrs. After 12hrs of sepsis activity score and vital data of all mice were recorded prior to killing. Plasma samples were collected and frozen following manufacturers guidelines until measurement. Determination of Interleukin (IL)-6, IL-10, monocyte chemoattractant protein-1 (MCP-1), Interferon-gamma (IFN-g), tumor necrosis factor alpha (TNF-a) and IL12-p70 was performed using a cytometric bead array (CBA, BD Biosciences, Heidelberg, Germany). CBA is combined b y six bead populations with distinct fluorescence intensities with specific capture antibodies. These bead populations are quantitatively measured using a flow cytometer. Differences between groups were evaluated by 1-way ANOVA.
Results: 12 hrs after CLP activity score was significantly higher in DAA-treated mice (score 1.8±0.7 (mean±SD); p=0.015) compared to control (score 3.1±0.9). HR tended to be higher in DAA and EA mice (DAA 547±175/min; EA 551±110/min; Control 530±143/min). MAP tended to be higher in DAA group and was similar after EA treatment when compared to control (DAA 111±26mmHg; EA 98±18mmHg; Control 97±4mmHg). IL-6 (DAA 2305±2211 pg/ml; EA 10612±4670 pg/ml; Control 7953±2408; p<0.05), IL-10 (DAA 74±86 pg/ml; EA 662±596 pg/ml; Control 1485±1429; p<0.01) and MCP-1 (DAA 1621±1084 pg/ml; EA 4960±2552 pg/ml; Control 5207±4193; p<0.05) were significantly lower after treatment with DAA but not with EA compared to control. All other investigated cytokines were not reduced by DAA.
In this model of murine sepsis DAA effectively inhibited different cytokines. EA treatment did not inhibit the investigated cytokines. DAA in experimental murine sepsis is capable to attenuate pro-inflammatory effects in a dose similar to those in humans. Results: On transcriptional level, we found ADAMTS13 in unstimulated HSC, HMEC-1 and HPLS. In all settings, incubation media secreted proteolytic activity was determined. After 24h, proinflammatory stimulation with interleukin 1beta, tumor necrosis factor and endotoxin in concentrations relevant to clinical conditions caused significant decrease of ADAMTS13-mRNA in dependence of the used normalisation transcript, which was mirrored in a decrease in proteolytic activity in incubation media (-64 %) . Also in HPLS, we found a significant decrease in both, mRNA and mature protein.
Conclusions:
To our knowledge for the first time we demonstrate in a human ex vivo setting a significant decrease in both, mRNA-synthesis and secretion of ADAMTS13 under proinflammatory conditions, which might contribute to the presence of high molecular weight VWF in plasma followed by activation of circulating platelets and the development of thrombotic microangiopathy. 
Background and aims:
The metalloproteinase ADAMTS13 plays a crucial role in haemostasis by cleaving the highly thrombogenic, ultralarge form of von-Willebrand-Factor (ULVWF), primarily immediately after endothelial secretion of ULVWF. Deficient activity of ADAMTS13 results in formation of vWF-rich thrombi characterised by a variety of clinical symptoms such as haemolysis, thrombocytopenia and micro-circulatory disturbances. Hepatic stellate cells are the principal site of ADAMTS13-biosynthesis, but mRNA was also detected in other cell types and tissues. In this study we examine the intracellular localisation of ADAMTS13 in the endothelial cell line HMEC-1 and its expression following stimulation with inflammatory cytokines. Methods: Immortalised human microvascular endothelial cells (HMEC-1) and hepatic stellate cells (LX-2) as positive control were analysed by flow cytometry and confocal immunofluorescence microscopy. Confluent cultures plated on dishes or chamber slides were stimulated with pro-inflammatory mediators (i.e. TNF-alpha, LPS, Il1-beta) and labelled with endothelial cell-specific primary and secondary antibodies (ICAM-1, CD62P, vWF). The mean fluorescent intensity (MFI) and the percentage of positive cells of intracellular and surface-bound fluorescent molecules were analysed by FACScan flow cytometer. Fluorescent imaging of HMEC-1 by using AD-AMTS13-monoclonal antibodies was employed to localise AD-AMTS13.
Results:
The adhesion molecule ICAM-1 was up-regulated after stimulation with LPS, Il1-beta, TNF-alpha in a time and concentrationdependent manner. Interestingly, no CD62P (P-Selectin) signal on the surface of the endothelial cells was detectable. ADAMTS13 is expressed in HMEC-1, however fluorescence intensity is very weak in comparison to the endothelial marker protein vWF. Stimulation reduces the intracellular level of ADAMTS13 measured by the amount of antibody bound. Introduction: Hemoxygenases are enzymes converting heme into equal amounts of carbon monoxide (CO), biliverdin and free iron. Expression of the inducible isoform HMOX1 is up regulated in different tissues, including heart, lung, liver and monocytes by heme, cytokines, hypoxia, and other stimuli. The HMOX1 gene is encoded on chr22 and according the current annotation the gene structure is organized in 5 exons. However, expressed sequence tags (EST) support evidence for an additional exon upstream of exon1. Of major interest is a microsatellite in the form of a GT-dinucleotide repeat within the promoter region varying in lengths. The findings that (i) HMOX1 cleaves the toxic agent heme into anti-inflammatory agents (CO and biliverdin), (ii) the expression is up regulated by cytokines and (iii) the HMOX1 polymorphism may influence inflammatory response represents relevant factors to investigate the role of HMOX1 in sepsis and mu ltiple organ failure (MOF). Methods: DNA was separated from leukocytes of septic patients (n= 122) from either Jena or Homburg university hospital and clinical and laboratory data, including APACHE and SOFA scores, mortality rate were recorded on an observation period of five days. PCR, with primers flanking the GT-repeat, was performed either on patient DNA or a human DNA pool serving as an unaffected control. Fragment analysis was performed for evaluation of lengths of the (GT)n-Polymorphism. RNA from different tissue panels were used to demonstrate a "new" exon1 upstream the "former" exon1 of the HMOX1 gene by PCR, cloning and sequencing experiments. Results: The distribution of the (GT)n-lenght polymorphism displayed two peaks, at 23 and 30 repeat units in patients with sepsis and unaffected controls, therefore number of (GT)n-repeats were categorized into short (<25) and long (> 25) repeat units. Patients carrying at least one short allele [(s/s, n=13) or (s/l, n=52)] exhibited lower SOFA scores on day 5 (6,93 vs. 9,89; p=0,005) and enhanced difference between day 5 and 1 (-2,33 vs. -0,45; p=0,011) compared to (l/l, n=57). The SOFA difference between day 5 and 1 was greater in (s/s) and (s/l) than in (l/l) (-2,55 vs. -0,45; p=0,062 and -2,28 vs. -0,45; p=0,026, respectively) . In non-survivors, carrier of at least one short allele had significantly lower SOFA scores on day 5 (8,67 vs. 12,42, p=0,027) and an enhanced difference between day 5 and 1 (-1,83 vs. +0,62, p=0,05) compared to (l/l). (l/l) had higher SOFA scores than (s/l) at day 5 (12,42 vs. 8,93, p=0,05) , but there was no difference neither between (s/s) and (l/l) nor between (s/s) and (s/l). The SOFA difference between day 5 and 1 within the non-survivors was significantly greater in (s/s) and (s/l) than in the (l/l) group (-3,00 vs. +0,62, p=0,039 and -1,50 vs. +0,62, p=0,014 respectively). cDNA sequencing analysis in different tissues supported evidence for a "new" exon1 upstream the "former" exon1 and alternative splicing variants of HMOX1 gene, with or without intron retention of the (GT)n-polymorphism, could be found.
Conclusion:
The (GT)n-length polymorphism of HMOX1 may influence sepsis course and outcome depending on the number of the (GT)n-repeat length, however due to the limited number of patients no information is available on a varied predisposition for sepsis. The structure of the HMOX1 gene needs to be reevaluated by inserting a novel exon1 upstream of the former exon1. Splicing variants include the (GT)n-length polymorphism by intron retention, probably depending in the number of repeat units. Introduction: Hepatic failure still represents the prominent prognosis limiting factor in patients with severe sepsis. Hypoxia caused by septic shock and perfusion failure, as well as inflammatory mediators, released by several kinds of immuno-competent cells, are both initial factors for sepsis-induced liver dysfunction. In addition to the ensuing progressive loss of a critical number of metabolically active cells through necrosis and apoptosis, the differential regulation of hepatic transporter proteins (e.g. OATP1, BSEP, MRP2, etc.) is also thought to cause a disturbance in hepato-cellular clearance function and thus to result in the pathophysiological pattern of liver dysfunction. This is of particular interest regarding the hepato-biliar clearance of a variety of pharmacological substances administered under these conditions. Methods: To assess the expression-modulating effects of either hypoxia or inflammatory mediators in cultured human precision liver slices (HPLS) as an ex-vivo model mimicking the hepato-cellular environment under septic conditions. To achieve prototypical cellular events during sepsis, human precision liver slices prepared from surgical waste material were incubated for 0, 6, and 24 hours under standard conditions with i) mixed inflammatory mediators or ii) 2,6-dimethyl-2,5-heptadien-4-one (depletion of the cellular glutathione content) to simulate septic, pro-inflammatory conditions and sepsis-induced oxidative stress, respectively. Transcription levels of selected transporters were determined by Real-time PCR run on an iCyclerTM (Biorad). Results were normalised to the unvaried housekeeping gene hypoxanthine ribosyl transferase (HPRT). Results: In both settings, i.e. inflammatory stimulation and oxidative stress we demonstrated differential changes in gene expression of individual basolateral and canalicular transporter proteins as well as group-associated differences in the expression of basolateral as opposed to canalicular transporters. Although some transporters displayed robust or even increased expression (e.g. OATP1, NTCP), the majority of the investigated transporter proteins showed steady state transcript concentrations that were substantially decreased: Particularly sensitive proteins were the basolateral transporter proteins MRP3 and OATP2 as well as the canalicular transporters MRP2, MDR3 and the bile salt export pump (BSEP), with the canalicular transporters overall more sensitive to either intervention than the basolateral ones.
With this study we demonstrated directed steady state transcript variations to noxious stimuli in cultured HPLS for various transporters. These expression patterns might reflect a mechanism for a disturbance in hepato-cellular excretory function and could, therefore, lead to non-uptake from sinusoidal blood flow or accumulation of potentially toxic products within the hepatocytes, hence promoting the development of sepsis-induced cholestasis or liver dysfunction.
Introduction:
Besides severe side effects Glucocorticoids (GCs) are widely used for treatment of inflammatory diseases. However, the precise mechanism, how GCs repress inflammation, is not completely understood.
Objective: GCs bind to the Glucocorticoid Receptor (GR) -an ubiquitously expressed ligand-induced transcription factor. GR regulates expression of target genes through different mechanisms: 1) GR binds directly to a specific DNA sequence -Glucocorticoid Response Element (GRE) -and regulates the expression of nearby located genes. This mechanism depends on dimerization of GR. 2) GR interacts as a monomer with other transcription factors such as NF-kappaB, AP1, STAT5, and modulates their activity. It is believed that the second mechanism of GR action mediates the anti inflammatory activity of GCs.
Methods and results:
By the use of conditional GR knockout mice (GRlysMcre mice) we could show that the presence of the GR in myeloid cells is required for anti-inflammatory effects of GCs in septic shock model. Furthermore in knock-in mice that express a dimerization defective GR (GRdim), we could demonstrate that dimerization of glucocorticoid receptor is necessary for the repression of inflammation by GCs. We found that GCs could not completely repress LPS Critically ill patients undergoing intensive care treatment bear a significant risk of aquiring an invasive fungal infection. Their immune defense may be severely compromised by corticosteroids or other immunosuppressive agents, and their skin and mucosal integrity is often markedly disrupted by open wounds (particularly in burn patients) and invasive devices. Catheter-associated invasive Candida infections are among the most frequently observed infectious complications. Early diagnosis, prompt intervention with systemic antifungal therapy and removal of intravascular devices have been shown to be of significant benefit in terms of morbidity and mortality. The local epidemiology, especially the relevance of fluconazole-resistant Candida spp., should be carefully taken into consideration when the antifungal agent for first-line intervention is selected. Antifungal treatment should be continued for at least 14 days after the f irst negative blood culture. In high-risk surgical ICU patients, antifungal prophylaxis may be beneficial. Organ transplant recipients, severely immunocompromised and neutropenic patients, such as those undergoing allogeneic hematopoietic stem cell transplantation or intensive antileukemic chemotherapy, as well as burn patients and patients with severe chronic pulomary diseases are at risk for invasive pulmonary aspergillosis. Early CT scans may show typical lesions, i.e., nodules surrounded by glass-ground opacities ("halo" sign) or an air-crescent sign indicating a more advanced disease. Bronchoscopy plus bronchoalveolar lavage in order to obtain samples for culture, histopathology, Aspergillus antigen and eventually PCR may help to prove the filamentous fungal origin. Paranasal sinuses may be affected as well as the central nervous system, so that these sites should be examined thoroughly and eventually taken into account for obtaining additional samples for diagnostic procedures. Early intervention with a highly effective systemic antifungal is mandatory. When chosin g the appropriate antifungal agent, co-medications interacting with cytochrome P450 isoenzymes have to be considered. Pharmacokinetic properties, particularly with respect to tissue penetration, and safety profiles of available antifungal should be carefully taken into consideration when treatment choices are made. It is important to know that in patients with invasive pulmonary aspergillosis, response in terms improvement of CT findings may not be expected until 10 to 14 days of full-dose antifungal therapy have been given. Here, data on the robustness and diagnostic reliability of the test as obtained for 1186 blood samples from 396 ICU patie nts with suspected sepsis and 137 controls are presented. In addition, supplementary microbiological test results generated throughout these studies are discussed. PCR starting from 1.5 ml and from 3 ml blood were equally sensitive and specific. However, performance of PCR starting from 1.5 ml instead of 3 ml blood blood turned out more robust. Obviously, the average time-to-report is much longer for conventional BC compared to PCR while PCR detection rate for various microorganisms is significantly higher compared to BC. In a subgroup of 53 healthy controls and 65 patients with suspected sepsis that was analyzed at our institution from 06/2005 to 02/2006 by PCR and conventional cultures under routine laboratory conditions, the concordance of positive BCs with positive PCR results was 71.4%. Concordance of negative PCR results with negative BC results was 75.3% mainly due to the higher rate of PCR positives. Analytical specificity of PCR in patients without evidence of sepsi s was 98.9%. If constructed gold standards (clinical judgment, additional microbiological data) were used to adjust for the potentially lower sensitivity of BC, the correlation with PCR was 87.5% and 90.4% for positive and negative results, respectively, in the 118 patients investigated at our centre. Compared with conventional BC, PCR, obviously, detects more microorganisms in patients with BSI while the results in the control group suggest high specificity. Reflecting on a meta-analysis of currently available study data the potentials and limitations of this new technology will be discussed and commented on from the perspective of a clinical microbiologist in the context of additional clinical and microbiological information. cases of death per year sepsis is the third leading cause of death after coronary artery disease and acute myocardial infarction. In the last years enormous progress in the therapy of sepsis was achieved. Although the 28-day-mortality in the prevalence study [2] was still at 54%, e.g. the work of Kortgen et al. [3] showed, that with stringent compliance to the sepsis guidelines and implementation of the 6-and 24-hours therapy bundles the mortality may be lowered significantly below 30%. The therapy costs per day for intensive care medicine amount to ca. 1.000 € per patient day [4] . More than 40% of the costs are for personnel. Therefore the goal should be to lower the time spent in the intensive care unit, and also in the hospital, through optimized therapy according to the guidelines, while at the same time improving mortality and morbidity. Garland et al. [5] showed, that second to length of stay as the greatest independent cost factor in an intensive care unit, the individual treatment of the physician is the next greatest independent cost factor for intensive care therapy. In conclusion these studies indicate that for therapy of sepsis it is absolutely imperative, to implement the sepsis bundles according to the guidelines. With it not only mortality and morbidity are improved, but with shortened length of stay costs decrease. In the work of Nguyen [6] was explained, that with an appropriate training program f or all employees of the intensive care unit an implementation of the sepsis guidelines succeeds. As Shorr et al. [7] showed, this also leads to a reduction of direct costs. In summary it may be said that with costs of 1,000 € per day for intensive care therapy, the treatment of severe sepsis belongs to the most expensive syndromes. Still with consistent implementation of the current existing guidelines in the daily treatment routine the quality may increase and therapy cost may decrease Children hospitals in Germany are often in a financial deficiency. They are mostly not able to compete with the great departments of adult surgery or internal medicine. On one hand the amount of patients is low, otherwise the reference of the costs in the DRG-System Satellite Symposia is not adequate. Children hospitals are commonly interdisciplinary medical facilities. The units are small with an extraordinary expense of health personnel and technical equipment. The poor financial situation is legitimated as an investment in the future of the population. About the small dimension of the single pediatric departments, intensive networking with tertiary children hospitals and other clinics in the surrounding is essential and has a long tradition. The mentioned conditions and deficits had maintained to some changes in the working procedures. Because of the inner children-hospital availability of widespread competence, the communication channel is short and fast. Usually there is no significant time delay between recognition of the seriously ill child and the integration of different pediatric departments in diagnosis and therapy. The strict centralisation in the pediatric networks benefits a very early integration of the tertiary centers in the treatment of severe illness. Methods for adequate rescue therapies are mostly available only in these centers. This is a reason for fast transfer of the seriously ill child and therefore a better efficiency of the central hospitals. The short delays to the optimal treatment reduce costs and shorten the hospital stay. The retransfer after the successful intervention to the hospital of admission release new capacity of the tertiary center. Basic requirement for this procedere is a barrier free communication, collective continuing training and engaging therapy bundles. The competence of the tertiary center and the possibility of a transport-system have to be available 24 hour per day. In our pediatric intensive care network this system has carried to a significant improvement for example in the treatment of the WaterhouseFriderichsen Syndrome. All patients were treated with the common therapy algorithm. The gap till the first consultation of the tertiary center was between 15 to 60 min. Therapy bundles could work very effective. The primary and continous investment of training and communication is high, but much lower than the advantages of optimal therapy. The collaboration in our pediatric network was uncomplicated and fast. The implementation of the therapy strategies was effected in a short time. As a result of the optimized algorithm the medical costs could be reduced significantly. All participants of the network, including the patients, assessed the therapy bundle as a winwin situation. The typical interdisciplinary medical facilities in children hospitals and the traditional barrier free communication systems between pediatricians could be a good example for optimized medical structure. In the initial treatment of a critically ill patient, blood pressure, heart rate, urine output, and central venous pressure guide resuscitation. Despite normalization of these variables, global tissue hypoxia may still persist when the cardiorespiratory system is unable to cover metabolic demand adequately. In order to achieve adequate oxygen delivery, haemodynamic monitoring is necessary in order to provide appropriate cardiovascular support. Although measurements of regional perfusion and oxygenation are gaining increasing interest, cardiac output (CO) measurement is still regarded as the key haemodynamic variable in the assessment of cardiac function and guidance of therapy of critically ill patients. Flow, as gauged by CO, is the key measure of how well the circulation is delivering oxygen and nutrients to the vital organs and is the focus of all resuscitation efforts. Compared to thermodilution technique requiring the insertion of a pulmonary artery catheter the minimall-invasive continuous CO (CCO) represents an alternative, less-invasive technique for COmeasurement. This method of determining CO uses the arterial pres-strict protocol is needed for achieving a good reliability. The pulmonary artery (PA) catheter is an invasive tool to monitor acutely ill patients who need complex management. It provides three types of information, about intravascular pressures, measurement of cardiac output, and measurement of mixed venous oxygen saturation (SvO 2 ). Several prospective, randomized, controlled studies have indicated that using a PA catheter does not improve outcomes. These results are worrisome, because there can be only two interpretations: One is that the use of the PA catheter does not influence therapy (and thus cannot influence outcomes); the other is that it does influence therapy but that the changes in therapy do not improve outcome (i.e., our interventions are useless). Taking the second scenario, it seems unlikely that all ICU interventions are useless, first because there would simply be no need for our specialty if that were the case, but second, because there are a number of studies indicating that the intervention of an intensivist can indeed positively influence outcomes. Therefore, if our interventions can be beneficial, perhaps it is the way in which the PA catheter findings are interpreted and used which is inadequate and I suggest that we need to revisit the basics of haemodynamic management and reassess the way in which the PA catheter is used, insisting on a strict three step process: 1. Correct measurement: pay attention to zeroing, calibration, elimination of artefacts, proper reading of the values -unfortunately, many errors are made in data collection. 2. Correct interpretation: this is based on a good knowledge of physiology and a complete integration of the three types of elements (pressures, cardiac output, and SvO 2 ) -unfortunately, there are still many clinicians who neglect simple elements like the pressure difference between the PA diastolic pressure and the PA occlusion pressure (PAOP), or between the PAOP and the right atrial pressure (RAP), or who measure cardiac output without concurrent SvO 2 … 3. Correct application: data collection and interpretation is still useless if the results are not correctly applied to guide management. Unfortunately, even when data are correctly collected and interpreted, it is not uncommon to find that they have not been correctly applied to the individual patient and therapy with, e.g., fluids and inotropic agents remains suboptimal. Some people may argue that to improve application we need therapeutic protocols. However, the PA catheter is indicated only in patients with complex issues influenced by multiple components; designing global protocols to guide therapy for such patients would be a difficult task and would represent an attempt to replace the good physician at the bedside. Just as interpretation of chest X-rays cannot be automated, proper haemodynamic management requires a good doctor at the bedside to integrate the individual factors present in each patient into a patient-specific management package. Let us concentrate our efforts on the training of such doctors.
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